Akcea Therapeutics Inc. (AKCA) Declined -6.19% or -1.42 To Price $21.52 On Thursday


Akcea Therapeutics Inc. (AKCA) declined -6.19% or -1.42 to $21.52. It is near 110739 shares traded, which is 54.8% compare to the average total volume 202096. The market cap of AKCA is $2.00 billion. The year to date change is -31.54%. The 52 week price range is from $19.67 to $40.75. Price of AKCA have changed 5.62% during last week. It have changed -12.24% over last month, -29.52% over last 3 months, -28.56% over last 6 months and -0.43% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKCA is 25.61. It is 19.01% above current price. The 200-day Moving Averages for AKCA is 28.04. It is 30.30% above current price. The 52-week High is 40.75. It is 89.36% from the current price. The 52-week Low is 19.67. It is -8.60% from current price.

There are some statistics of AKCA. It is has market cap $2.00 billion. The share outstanding is 92.77 million. The average volume is 202096. The percent of top 15 Institution holding is 46.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKCA is -64.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKCA is -49.08%.


Tags:

Share this post